An in-vivo pilot study into the effects of FDG-mNP in cancer in mice.
Omer ArasGillian PearceAdam J WatkinsFuad NuriliEmin Ilker MedineOzge Kozgus GulduVolkan TekinJulian WongXianghong MaRichard TingPerihan UnakOguz AkinPublished in: PloS one (2018)
Intravenous or intratumoural FDG-mNPs can be safely administered for effective cancer cell destruction. Further research on the clinical utility of FDG-mNPs will be conducted by applying hyperthermia in conjunction with FDG-mNPs in mice.